Werewolf Therapeutics, Inc.
HOWL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001785530
In the last 90 days, Werewolf Therapeutics, Inc. insiders filed 0 open-market purchases and 2 sales; 45 institutions reported holding it in 13F filings for Q2 2026, worth $3.91M in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Werewolf Therapeutics, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 45
- +45 vs. Q1 2021
- Shares held
- 19.8M
- +19.8M vs. Q1 2021
- Total value
- $344.3M
- +$344.3M vs. Q1 2021
- New holders
- 45
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HOWL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 45 | $3.91M |
| Q1 2026 | 48 | $11.7M |
| Q4 2025 | 51 | $9.34M |
| Q3 2025 | 62 | $41.6M |
| Q2 2025 | 65 | $24.3M |
| Q1 2025 | 70 | $26.7M |
| Q4 2024 | 73 | $41.7M |
| Q3 2024 | 69 | $68.3M |
| Q2 2024 | 71 | $79.3M |
| Q1 2024 | 61 | $209.7M |
| Q4 2023 | 41 | $106.8M |
| Q3 2023 | 35 | $51.1M |
| Q2 2023 | 36 | $73.3M |
| Q1 2023 | 38 | $62.5M |
| Q4 2022 | 39 | $42.8M |
| Q3 2022 | 44 | $94.5M |
| Q2 2022 | 46 | $78.0M |
| Q1 2022 | 49 | $84.3M |
| Q4 2021 | 51 | $228.4M |
| Q3 2021 | 42 | $326.2M |
| Q2 2021 | 45 | $344.3M |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Werewolf Therapeutics, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 4,291,881 | $74.8M | 1.20% | +4,291,881 | New |
| MPM Asset Management LLC | 4,284,172 | $74.7M | 13.89% | +4,284,172 | New |
| Deerfield Management Company, L.P. (Series C) | 2,552,787 | $44.5M | 0.79% | +2,552,787 | New |
| MPM Oncology Impact Management LP | 2,388,011 | $41.6M | 6.84% | +2,388,011 | New |
| Adage Capital Partners GP, L.L.C. | 1,000,597 | $17.4M | 0.03% | +1,000,597 | New |
| Sphera Funds Management Ltd. | 706,294 | $12.0M | 1.09% | +706,294 | New |
| Avidity Partners Management LP | 650,265 | $11.3M | 0.31% | +650,265 | New |
| DC Funds, LP | 589,102 | $10.3M | 48.81% | +589,102 | New |
| Soleus Capital Management, L.P. | 563,396 | $9.83M | 1.51% | +563,396 | New |
| PFM Health Sciences, LP | 400,000 | $6.98M | 0.22% | +400,000 | New |
| BlackRock Inc. | 365,863 | $6.38M | 0.00% | +365,863 | New |
| FMR LLC | 315,000 | $5.49M | 0.00% | +315,000 | New |
| Nicholas Investment Partners, LP | 294,654 | $5.14M | 0.32% | +294,654 | New |
| Platinum Investment Management Ltd | 206,915 | $3.61M | 0.08% | +206,915 | New |
| Alyeska Investment Group, L.P. | 206,201 | $3.60M | 0.04% | +206,201 | New |
| Migdal Insurance & Financial Holdings Ltd. | 187,500 | $3.27M | 0.03% | +187,500 | New |
| Vanguard Group Inc | 173,127 | $3.02M | 0.00% | +173,127 | New |
| Geode Capital Management, LLC | 108,178 | $1.89M | 0.00% | +108,178 | New |
| Caas Capital Management LP | 100,000 | $1.74M | 0.09% | +100,000 | New |
| State Street Corp | 78,237 | $1.36M | 0.00% | +78,237 | New |
| Northern Trust Corp | 75,774 | $1.32M | 0.00% | +75,774 | New |
| Goldman Sachs Group Inc | 37,435 | $653.0K | 0.00% | +37,435 | New |
| Aristides Capital LLC | 25,585 | $446.0K | 0.34% | +25,585 | New |
| Bank of New York Mellon Corp | 22,213 | $387.0K | 0.00% | +22,213 | New |
| Evercore Wealth Management, LLC | 21,500 | $375.0K | 0.01% | +21,500 | New |
| Charles Schwab Investment Management Inc | 16,038 | $280.0K | 0.00% | +16,038 | New |
| Arena Capital Advisors, LLC- CA | 14,958 | $261.0K | 0.02% | +14,958 | New |
| New York State Common Retirement Fund | 13,031 | $227.0K | 0.00% | +13,031 | New |
| Nuveen Asset Management, LLC | 12,001 | $209.0K | 0.00% | +12,001 | New |
| Schonfeld Strategic Advisors LLC | 11,300 | $197.0K | 0.00% | +11,300 | New |
| California State Teachers Retirement System | 10,465 | $183.0K | 0.00% | +10,465 | New |
| Capstone Investment Advisors, LLC | 10,000 | $174.0K | 0.00% | +10,000 | New |
| JPMorgan Chase & Co | 9,352 | $163.0K | 0.00% | +9,352 | New |
| Deutsche Bank AG | 4,492 | $78.0K | 0.00% | +4,492 | New |
| American International Group, Inc. | 4,241 | $74.0K | 0.00% | +4,241 | New |
| Citigroup Inc | 2,016 | $35.0K | 0.00% | +2,016 | New |
| STRS Ohio | 1,800 | $31.0K | 0.00% | +1,800 | New |
| UBS Group AG | 1,000 | $17.0K | 0.00% | +1,000 | New |
| Legal & General Group Plc | 736 | $13.0K | 0.00% | +736 | New |
| Ameritas Investment Partners, Inc. | 593 | $10.0K | 0.00% | +593 | New |
| Royal Bank of Canada | 519 | $9.00K | 0.00% | +519 | New |
| Bank of America Corp | 487 | $8.00K | 0.00% | +487 | New |
| Morgan Stanley | 267 | $5.00K | 0.00% | +267 | New |
| Financial Perspectives, Inc | 250 | $4.36K | 0.00% | +250 | New |
| Tower Research Capital LLC (TRC) | 52 | $1.00K | 0.00% | +52 | New |